Letters, Testimony & Comments

January 20, 2006
BIO's Comments on the Centers for Medicare and Medicaid Servicesí interim final rule regarding exclusion of vendor purchases made under the Competitive Acquisition Program (CAP) for outpatient drugs and biologicals under Part B.
January 6, 2006
To United States Pharmacopeia
December 23, 2005
BIO's Comments on the Centers for Medicare and Medicaid Services' final rule regarding revisions to payment policies under the Medicare physician fee schedule and certain provisions related to the Competitive Acquisition Program.
December 14, 2005
BIOís comments on Noridian Admistrative Services draft LCD regarding drugs and their covered diagnosis.
December 13, 2005
BIO's comments on the Office of Inspector General's proposed Rule regarding new Safe Harbors for e-prescribing
November 14, 2005
October 28, 2005
Notices of new systems of records: "Data Collection Secondary to Coverage Decision System," "Anti-Cancer Chemotherapy for Colorectal Cancer System," and "Carotid Artery Stenting System"
October 3, 2005
Dear Governor Doyle: On behalf of the Biotechnology Industry Organization (BIO) and the Wisconsin Biotechnology and Medical Device Association, I am writing to express concern with legislation that has been forwarded to you by the Wisconsin...
September 30, 2005
BIO urges the ICTRP to focus on developing a procedure that would address the need to balance the incentive to innovate with the need to provide patients and health care providers with the information they need in order to assess the availability...
September 30, 2005
Comments by BIO; CMS-1502-P (Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2006)